Showing results (871-880 of 1,190) with videos related to

Sort By:
Pageof 119
Cancer|May 29, 2024
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantationJayastu Senapati, Hagop M Kantarjian, Alexandre Bazinet, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 3, 2022
Immunohistochemical loss of enhancer of Zeste Homolog 2 (EZH2) protein expression correlates with EZH2 alterations and portends a worse outcome in myelodysplastic syndromesAli Sakhdari, Caleb Class, Guillermo Montalban-Bravo, et al.
Blood|October 21, 2016
KIR gene haplotype: an independent predictor of clinical outcome in MDS patientsKate Stringaris, David Marin, A John Barrett, et al.
Leukemia & Lymphoma|April 9, 2020
Results of a Phase 1/2a dose-escalation study of FF-10501-01, an IMPDH inhibitor, in patients with acute myeloid leukemia or myelodysplastic syndromesGuillermo Garcia-Manero, Naveen Pemmaraju, Yesid Alvarado, et al.
Nature Immunology|December 27, 2016
Ubiquitination of hnRNPA1 by TRAF6 links chronic innate immune signaling with myelodysplasiaJing Fang, Lyndsey C Bolanos, Kwangmin Choi, et al.
American Journal of Hematology|September 19, 2022
Implications of RAS mutational status in subsets of patients with newly diagnosed acute myeloid leukemia across therapy subtypesDaniel Rivera, Kunhwa Kim, Rashmi Kanagal-Shamanna, et al.
Blood Advances|December 19, 2023
Prognostic risk signature in patients with acute myeloid leukemia treated with hypomethylating agents and venetoclaxAlex Bataller, Alexandre Bazinet, Courtney D DiNardo, et al.
American Journal of Hematology|February 16, 2024
Targetable genetic abnormalities in patients with acute myeloblastic leukemia across age groupsAlex Bataller, Courtney D DiNardo, Alexandre Bazinet, et al.
Blood|August 3, 2006
Phase 1/2 study of the combination of 5-aza-2'-deoxycytidine with valproic acid in patients with leukemiaGuillermo Garcia-Manero, Hagop M Kantarjian, Blanca Sanchez-Gonzalez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 16, 2012
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndromeGuillermo Garcia-Manero, Francesco Paolo Tambaro, Nebiyou B Bekele, et al.
Pageof 119